We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 19.80 | 19.60 | 20.00 | 19.80 | 19.80 | 19.80 | 80,955 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.18M | -3.3M | -0.0753 | -2.63 | 8.68M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/8/2023 07:17 | 486 views in two years... but you have inadvertently illustrated the lack of interest in the product from this low number of views. Most of the other YouTube Bleepa videos got around 100 views. Even I felt embarrassed at seeing how low the views were. If all is well, shareholders alone would produce more visits than this. | ydderf | |
28/8/2023 15:36 | In the four or five years since Bleepa arrived there have been many emergent competitors, some of which now have commercial traction and revenue in various niches. I am at a loss to understand what the case is for Bleepa after all these years. Please can one of the regulars educate me and others here who may be recent shareholders but not aware of the business case ? Ps Is the collapsing NHS the only real potential buyer for it? | ydderf | |
17/8/2023 17:03 | Very late reported trade. 16-Aug-23 13:22:34 89.50 103,571 Unknown* 85.00 90.00 92.70k | lr2 | |
16/8/2023 20:27 | So, I take it you are not expecting any news in the morning? | lr2 | |
16/8/2023 18:55 | Team meeting! Probably all working from home. Zoom call for 2 mins, anything new? No. Ok can get back to mowing the lawn. This is becoming a farce. Surely shareholders can remove these muppets!? before they devour the remaining £7m cash. | ducatiman | |
15/8/2023 16:33 | Team meetings must be a hoot... | davwal | |
15/8/2023 13:50 | The TO wealth generation fund seems to be going along its usual path. Hot air occasionally, and b-all sales worldwide. Just incredible. | davwal | |
08/8/2023 11:25 | According to Dr. Matt Kneale, co-chair of the Doctors' Association UK, "The Government is showing a disregard for core NHS issues. We call on them to tackle the root causes of the backlog & staffing shortages -- prioritise investment in retention and expansion of workforce, infrastructure & capacity. Outsourcing is not acceptable." More radiologists and clinical oncologists are needed to keep up with demand, the Royal College of Radiologists noted on 7 August. "Most consultants who left the workforce last year were under 60, with many suffering burnout." I'm not sure about impressed never mind 'overly'. I thought we were all calling for him to buy some shares in the company he has talked up but not delivered. Some sympathy in that he's trying to work with the NHS but certainly not impressed. | ged5 | |
07/8/2023 12:32 | @BleepaMe is your compliant, secure platform for clinical communication. UKCA-accredited, encrypted and zero-footprint. Find out more and book your demo today: [...] | lr2 | |
03/8/2023 17:13 | Bleepa @BleepaMe · 3h "To truly turnaround our cancer performance [...] we need two key things: Effective communication and a well-implemented tool kit to make this happen." Read our latest article from Kira Pennington here 👉[...] | lr2 | |
03/8/2023 01:01 | Thought I'd post a link to the Bleepa-Carelocker Pricing document so anyone from NHS Lanarkshire looking in here can do some calculations and start budgeting for their new medical discussions system. | lr2 | |
02/8/2023 15:58 | What a clown, must be short. | ducatiman | |
19/7/2023 10:26 | Interesting I thought | ydderf | |
19/7/2023 10:25 | Interesting I thought | ydderf |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions